Related Experiment Video
Updated: Mar 23, 2026
08:50
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
24.5K
Sodium intake, RAAS-blockade and progressive renal disease
Martin H de Borst1, Gerjan Navis1
1Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Pharmacological Research
|April 5, 2016
Summary
Dietary sodium restriction enhances kidney protection from renin-angiotensin-aldosterone system (RAAS) blockade in chronic kidney disease (CKD) patients. Behavioral interventions may help patients achieve lower sodium intake, improving cardio-renal outcomes.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Dietary Science
Background:
- Renin-angiotensin-aldosterone system (RAAS) blockade is standard for slowing chronic kidney disease (CKD) progression.
- RAAS blockade's renal protective effects are often incomplete.
- Dietary sodium restriction amplifies the benefits of RAAS blockade.
Purpose of the Study:
- To investigate the impact of sodium intake on RAAS blockade efficacy in CKD.
- To explore methods for improving patient adherence to sodium restriction.
- To assess the potential of behavioral interventions for better cardio-renal outcomes.
Main Methods:
- Analysis of 24-hour urinary sodium excretion data from over 10,000 CKD patients and renal transplant recipients.
- Review of existing clinical studies on sodium restriction and RAAS blockade.
- Consideration of behavioral approaches like e-health coaching and 24-hour urine collection feedback.
Main Results:
- CKD patients consume high levels of sodium (average 3.8g/day), similar to the general population.
- Moderate sodium restriction (around 2.5g/day) shows significant benefits.
- High sodium intake may counteract the protective effects of RAAS blockade.
Conclusions:
- Optimizing sodium intake is crucial for maximizing RAAS blockade benefits in CKD.
- Achieving sodium restriction in CKD patients is challenging but essential.
- E-health and feedback interventions show promise for lowering sodium intake and improving patient outcomes.
Related Concept Videos
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.8K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:11Renal Failure: Dose Adjustments
571
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
571
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.8K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
01:29Renal Regulation of Acid-Base Balance
2.2K
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
2.2K
01:28Chronic Kidney Disease III: Interprofessional Care
595
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595